CIK: 1634632 - Address: 1700 Owens Street, Suite 595, San Francisco, CA 94158
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/17/22 17:12
5/13/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,37610.450-132-62,156D
5/12/22 20:47
5/10/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,67210.390-161-72,288D
5/9/22 18:58
5/5/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-89910.370-87-32,448D
5/4/22 19:30
5/2/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-2,80910.380-271-102,535D
4/29/22 17:50
4/27/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,97310.380-190-62,806D
4/26/22 18:40
4/22/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-1,34810.390-130-42,996D
4/21/22 20:54
4/19/22
CMPICheckmate Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagVenbio Global Strategic Fund II L.P.CATS.m-5,70010.410-548-153,126D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact